Corticosteroids and septic shock

JAMA

Volumn 288, Issue 7, 2002, Pages 886-887

  Abraham, Edward ^a   Evans, Timothy ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN; FLUDROCORTISONE; HYDROCORTISONE;

CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; EDITORIAL; HUMAN; HYDROCORTISONE BLOOD LEVEL; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPTIC SHOCK; SURVIVAL; TREATMENT OUTCOME;

EID: 0037151455     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.288.7.886     Document Type: Editorial

References (18)

1. Effect of cortisone on acute streptococcal infections and post-streptococcal complications
2. Corticosteroid treatment for sepsis: A critical appraisal and meta-analysis of the literature
3. Steroid controversy in sepsis and septic shock: A meta-analysis
4. Steroids in the treatment of clinical septic shock
5. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock
6. Reversal of late septic shock with supraphysiologic doses of hydrocortisone
7. Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study
8. Adrenal insufficiency occurring during septic shock: Incidence, outcome, and relationship to peripheral cytokine levels
9. Corticosteroid therapy in severe illness
10. Cortisol response to corticotropin and survival in septic shock
11. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin
12. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock
13. Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of I kappa B synthesis
14. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome
15. New rationale for glucocorticoid treatment in septic shock
16. Efficacy and safety of recombinant human activated protein C for severe sepsis
17. Ventilation with lower tidal volume as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome
18. Intensive insulin therapy in critically ill patients